Unique ID issued by UMIN | C000000212 |
---|---|
Receipt number | R000000282 |
Scientific Title | Effects of 3-hydroxy-3-methyglutaryl-coenzyme A (HMG-CoA) reductase inhibitor upon carotid intima-media complex thickness in the post-ischemic patients with hyperlipidemia during the prospective study of J-STARS. |
Date of disclosure of the study information | 2005/09/13 |
Last modified on | 2019/06/12 11:12:55 |
Effects of 3-hydroxy-3-methyglutaryl-coenzyme A (HMG-CoA) reductase inhibitor upon carotid intima-media complex thickness in the post-ischemic patients with hyperlipidemia during the prospective study of J-STARS.
Carotid intima-media thickness in Japan Statin Treatment Against Recurrent Stroke (J-STARS echo sub Study)
Effects of 3-hydroxy-3-methyglutaryl-coenzyme A (HMG-CoA) reductase inhibitor upon carotid intima-media complex thickness in the post-ischemic patients with hyperlipidemia during the prospective study of J-STARS.
Carotid intima-media thickness in Japan Statin Treatment Against Recurrent Stroke (J-STARS echo sub Study)
Japan |
Ischemic stroke
Neurology | Neurosurgery |
Others
NO
This study establish an effect of HMG-CoA reductase inhibitor upon intima-media complex thickness (IMT) of the common carotid artery from the ischemic stroke patients
Safety,Efficacy
Confirmatory
Pragmatic
Phase III
Intima-media complex thickness (IMT) of the common carotid artery (CCA)
Plaque score, number of plaque, recurrent cerebrovascular events
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
YES
YES
Institution is considered as adjustment factor in dynamic allocation.
YES
Central registration
2
Prevention
Medicine |
Patients will be randomized into the group receiving pravastatin or that having no statin. Intervention consists of pravastain treatment (10mg/day), that will start within 1 month of entry and continue until the full duration of study or the end-points.
Non-administration group of pravastatin (control group)
45 | years-old | <= |
80 | years-old | >= |
Male and Female
1) Ischemic stroke except for cardiogenic embolism, from 1 month to 3 years after onset
2) 45-80 years old
3) Patients diagnosed as hyperlipidemia
4) No medication of statin within previous 30 days.
5) The total cholesterol level of 180-240mg/dl under no prescription of statin in the previous 30 days
6) Able to visit outpatient department
7) Informed consent on the form filled out by the patient.
1) Ischemic stroke of other determined causea according to the TOAST classification
2) Ischemic heart disease necessary to require statin
3) Hemorrhagic disorders
4) Platelet count less than 100,000/ul within 3 months before study starts
5) Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) more than 100IU/L within 3 months prior to start of study
6) Serum creatinine more than 2.0mg/dl within 3 months prior to study.
7) Any scheduled operations.
8) The presence of malignant disorder
9) The patients participated in another clinical trial
10) The patient considered being unsuitable for the participation to the study by the medical doctor's judgment.
11) Patients whom carotid ultrasound cannot examine because of neck tumor or torticollis
12) Patients after carotid endarterectomy or radiation therapy to neck
800
1st name | Masayasu |
Middle name | |
Last name | Matsumoto |
Hiroshima University Graduate School of Biomedical and Health Sciences
Department of Clinical Neuroscience and Therapeutics
734-8551
1-2-3 kasumi, Minami-ku, Hiroshima 734-8551, Japan
082-257-5200
naika3@hiroshima-u.ac.jp
1st name | Naohisa |
Middle name | |
Last name | Hosomi |
Hiroshima University Graduate School of Biomedical and Health Sciences
Department of Clinical Neuroscience and Therapeutics
734-8551
1-2-3 kasumi, Minami-ku, Hiroshima 734-8551, Japan
082-257-5201
http://jstars.umin.ne.jp
naika3@hiroshima-u.ac.jp
Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences
The Japanese Ministry of Health, Labour and Welfare
Other
Japan
National Cardiovascular Center
Hiroshima University Hospital Center for Integrated Medical Reserch
1-2-3 Kasumi, Minami-ku, Hiroshima
082-257-1752
protocol@cimr.hiroshima-u.ac.jp
NO
2005 | Year | 09 | Month | 13 | Day |
Partially published
Completed
2003 | Year | 12 | Month | 23 | Day |
2004 | Year | 04 | Month | 28 | Day |
2004 | Year | 03 | Month | 01 | Day |
2014 | Year | 02 | Month | 01 | Day |
2014 | Year | 03 | Month | 01 | Day |
2014 | Year | 04 | Month | 01 | Day |
2016 | Year | 03 | Month | 01 | Day |
2005 | Year | 09 | Month | 13 | Day |
2019 | Year | 06 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000282
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |